The tariff classification of Ranolazine Extended-Release Tablets and Oxcarbazepine Tablets in dosage form, from India
Reasoning
The tariff classification of Ranolazine Extended-Release Tablets and Oxcarbazepine Tablets in dosage form, from India
Cite this ruling
CBP Ruling N302361 (3004909230): The tariff classification of Ranolazine Extended-Release Tablets and Oxcarbazepine Tablets in dosage form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Zoledronic Acid Injection in dosage form, from India
The tariff classification of Cisplatin Injection in dosage form, from India
The tariff classification of Acetaminophen Injection in dosage form, from China
The tariff classification of Sapropterin Dihydrochloride Powder for Oral Solution in dosage from, from India
The tariff classification of Sapropterin Dihydrochloride Tablets in dosage form, from India